Rituximab in Newly Diagnosed Generalized Myasthenia Gravis: A New Treatment Paradigm?

JAMA Neurol. 2022 Nov 1;79(11):1100-1102. doi: 10.1001/jamaneurol.2022.2311.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Humans
  • Immunologic Factors / therapeutic use
  • Myasthenia Gravis* / drug therapy
  • Receptors, Cholinergic
  • Rituximab / therapeutic use

Substances

  • Rituximab
  • Receptors, Cholinergic
  • Immunologic Factors